Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 65.77% is in line with its 5-year average of 66.65%, around the middle of its 5-year range (62.72%–69.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.96% above its 12-month average of 65.14%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 65.82%.
GROSS MARGIN
65.77%
GROSS MARGIN AVG TTM
65.14%
GROSS MARGIN AVG 3Y
65.81%
GROSS MARGIN AVG 5Y
66.65%
GROSS MARGIN AVG 10Y
66.48%
GROSS MARGIN AVG 15Y
67.08%
GROSS MARGIN AVG 20Y
70.81%
CURRENT VS TTM AVG
+0.96%
CURRENT VS 3Y AVG
-0.06%
CURRENT VS 5Y AVG
-1.33%
CURRENT VS 10Y AVG
-1.06%
CURRENT VS 15Y AVG
-1.95%
CURRENT VS 20Y AVG
-7.12%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+11.48%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.37B
Gross Margin
65.77%
TTM Avg
65.14%
3Y Avg
65.81%
5Y Avg
66.65%
Market Cap
$10.83B
Gross Margin
90.69%
TTM Avg
90.21%
3Y Avg
89.67%
5Y Avg
89.38%
Market Cap
$10.80B
Gross Margin
64.75%
TTM Avg
63.66%
3Y Avg
64.40%
5Y Avg
64.61%
Market Cap
$12.08B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
Market Cap
$10.51B
Gross Margin
66.48%
TTM Avg
69.16%
3Y Avg
69.73%
5Y Avg
70.75%
Market Cap
$12.25B
Gross Margin
95.71%
TTM Avg
68.63%
3Y Avg
54.72%
5Y Avg
59.42%
Market Cap
$10.26B
Gross Margin
51.90%
TTM Avg
52.87%
3Y Avg
53.77%
5Y Avg
54.60%
Market Cap
$10.21B
Gross Margin
14.14%
TTM Avg
15.74%
3Y Avg
16.11%
5Y Avg
16.54%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.37B | 65.77% | 65.14% | 65.81% | 66.65% |
| DaVita Inc. (DVA)vs › | $11.46B | 31.02% | 29.95% | 30.17% | 30.48% |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 90.69% | 90.21% | 89.67% | 89.38% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 64.75% | 63.66% | 64.40% | 64.61% |
| Baxter International Inc. (BAX)vs › | $12.08B | 30.08% | 33.76% | 35.72% | 36.84% |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 66.48% | 69.16% | 69.73% | 70.75% |
| Encompass Health Corporation (EHC)vs › | $12.25B | 95.71% | 68.63% | 54.72% | 59.42% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 51.90% | 52.87% | 53.77% | 54.60% |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 14.14% | 15.74% | 16.11% | 16.54% |
| Penumbra, Inc. (PEN)vs › | $12.56B | 67.84% | 65.17% | 64.50% | 63.66% |
Gross Margin
65.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 65.82% |
| 2026-03-31 | 66.88% |
| 2025-12-31 | 64.65% |
| 2025-09-30 | 65.65% |
| 2025-06-30 | 62.72% |
| 2025-03-31 | 67.86% |
| 2024-12-31 | 65.27% |
| 2024-09-30 | 63.23% |
| 2024-06-30 | 66.43% |
| 2024-03-31 | 67.43% |
| 2023-12-31 | 64.78% |
| 2023-09-30 | 66.87% |
| 2023-06-30 | 67.93% |
| 2023-03-31 | 68.73% |
| 2022-12-31 | 67.52% |
| 2022-09-30 | 66.60% |
| 2022-06-30 | 69.51% |
| 2022-03-31 | 69.38% |
| 2021-12-31 | 68.22% |
| 2021-09-30 | 66.35% |
| 2021-06-30 | 67.92% |
| 2021-03-31 | 69.09% |
| 2020-12-31 | 67.29% |
| 2020-09-30 | 67.45% |
| 2020-06-30 | 64.44% |
| 2020-03-31 | 66.81% |
| 2019-12-31 | 65.65% |
| 2019-09-30 | 64.62% |
| 2019-06-30 | 66.92% |
| 2019-03-31 | 67.41% |
| 2018-12-31 | 64.76% |
| 2018-09-30 | 66.03% |
| 2018-06-30 | 67.78% |
| 2018-03-31 | 67.24% |
| 2017-12-31 | 66.06% |
| 2017-09-30 | 67.68% |
| 2017-06-30 | 65.38% |
| 2017-03-31 | 65.39% |
| 2016-12-31 | 64.55% |
| 2016-09-30 | 64.69% |
| 2016-06-30 | 66.56% |
| 2016-03-31 | 68.71% |
| 2015-12-31 | 67.48% |
| 2015-09-30 | 67.09% |
| 2015-06-30 | 67.22% |
| 2015-03-31 | 69.54% |
| 2014-12-31 | 67.66% |
| 2014-09-30 | 67.36% |
| 2014-06-30 | 68.73% |
| 2014-03-31 | 71.28% |
| 2013-12-31 | 69.74% |
| 2013-09-30 | 71.34% |
| 2013-06-30 | 74.38% |
| 2013-03-31 | 75.50% |
| 2012-12-31 | 73.60% |
| 2012-09-30 | 74.09% |
| 2012-06-30 | 74.81% |
| 2012-03-31 | 75.80% |
| 2011-12-31 | 73.89% |
| 2011-09-30 | 75.24% |
| 2011-06-30 | 76.00% |
| 2011-03-31 | 79.24% |
| 2010-12-31 | 77.52% |
| 2010-09-30 | 77.57% |
| 2010-06-30 | 79.26% |
| 2010-03-31 | 79.51% |
| 2009-12-31 | 79.66% |
| 2009-09-30 | 80.61% |
| 2009-06-30 | 77.41% |
| 2009-03-31 | 78.91% |
| 2008-12-31 | 78.30% |
| 2008-09-30 | 81.12% |
| 2008-06-30 | 79.51% |
| 2008-03-31 | 79.65% |
| 2007-12-31 | 79.48% |
| 2007-09-30 | 79.13% |
| 2007-06-30 | 78.27% |
| 2007-03-31 | 80.03% |
| 2006-12-31 | 79.60% |
| 2006-09-30 | 78.54% |
| 2006-06-30 | 77.29% |
| 2006-03-31 | 77.92% |
| 2005-12-31 | 77.73% |
| 2005-09-30 | 76.74% |
| 2005-06-30 | 79.29% |
| 2005-03-31 | 80.94% |
| 2004-12-31 | 78.84% |
| 2004-09-30 | 78.28% |
| 2004-06-30 | 79.19% |
| 2004-03-31 | 78.97% |
| 2003-12-31 | 77.94% |
| 2003-09-30 | 77.20% |
| 2003-06-30 | 75.70% |
| 2003-03-31 | 76.80% |
| 2002-12-31 | 74.86% |
| 2002-09-30 | 74.85% |
